Am J Transplant, Volume 21, Suppl 3 Archives - Page 94 of 139 - ATC Abstracts

2021 American Transplant Congress
Anterior Rectus Sheath versus Gibson Incision for Kidney Transplantation – University of Chicago Experience
G. S. Generette, P. J. Bachul, P. E. Borek, K. Jayant, A. Perez-Gutierrez, B. Juengel, Y. T. Becker, R. Barth, J. Fung, P. Witkowski
Surgery, University of Chicago, Chicago, IL
*Purpose: The advantages of Anterior Rectus Sheath (ARS) incision over traditional Gibson (GB) incision have been described for kidney transplantation. Therefore, we decided to compare…
2021 American Transplant Congress
Body Surface Adjusted vs Raw GFR in Predicting Long Term Outcomes of Kidney Donors. Who is Disadvantaged?
H. N. Ibrahim¹, S. A. Hebert¹, H. E. Adrogue¹, D. Murad¹, D. T. Nguyen², E. A. Graviss²
¹Medicine, Houston Methodist Hospital, Houston, TX, ²Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX
*Purpose: KDIGO and others recommend that GFR level acceptance (typically >80 ml/min) should be adjusted for body surface area (BSA) as GFR correlates highly with…
2021 American Transplant Congress
Bortezomib for Antibody-Mediated Rejection of Renal Transplant in Youth
L. Galea, J. Hewlett, J. Savant, S. Lopez, S. Amaral, B. Viteri
The Children’s Hospital of Philadelphia, Philadelphia, PA
*Purpose: The purpose of the study was to examine preliminary efficacy and tolerability of bortezomib, a protease inhibitor, in treatment-refractory antibody mediated rejection (AMR) in…
2021 American Transplant Congress
A2 to B Deceased Donor Renal Transplantation Outcome Analysis: Single Center Experience
S. Bindroo, M. Doshi
Nephrology, University of Michigan, Ann Arbor, MI
*Purpose: Initial experience under kidney allocation system (KAS) implemented in December 2014 showed equivalent outcomes for A2 to B kidney transplantation compared with ABO compatible…
2021 American Transplant Congress
The Summarized Assessment of Endothelin a Receptors Expression in Renal Transplant Compartments is Associated with Antibody Mediated Rejection
M. Banasik¹, K. Nowanska¹, P. Donizy², K. Koscielska-Kasprzak³, S. Zmonarski¹, M. Kuriata-Kordek¹, A. Tukiendorf⁴, A. Hałoń², D. Janczak⁵, M. Krajewska¹
¹Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland, ²Department of Pathomorphology and Oncological Cytology, Wroclaw Medical University, Wroclaw, Poland, ³Research laboratory, Wroclaw Medical University, Wroclaw Medical University, Wroclaw, Poland, ⁴Department of Public Health, Wroclaw Medical University, Wroclaw, Poland, ⁵Department of General, Vascular and Transplant Surgery, Wroclaw Medical University, Wroclaw, Poland
*Purpose: The presence of non-HLA anti-endothelin A receptor antibodies may be important in transplant injury but the expression of the endothelin A receptor (ETA receptor)…
2021 American Transplant Congress
Impact of Donated Kidney Volume and Recipient Body Surface Area Incompatibility on the Allograft Outcomes with Pre-transplant Diabetes Mellitus
Y. Park¹, H. Lee², E. Ko², C. Yang², B. Chung²
¹Internal Medicine, Konyang University Hospital, Daejeon, Korea, Republic of, ²Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study was to analyze the impact on the adverse allograft outcome of transplanting relative small kidneys in patients with pre-transplant…
2021 American Transplant Congress
In Search of a Better Outcome: Opting Into the Live Donor Paired Kidney Exchange Program
A. J. Vinson¹, B. Kiberd², K. J. Tennankore¹
¹Nova Scotia Health Authority Division of Nephrology, Departm, Halifax, NS, Canada, ²Medicine, Dalhousie University, Halifax, NS, Canada
*Purpose: Live donor kidney transplantation is the best option for patients with End-Stage Kidney Disease (ESKD), if a donor is available. However, this may not…
2021 American Transplant Congress
Obesity is a Risk Factor for Progression to Kidney Transplant Waitlisting After Liver Transplantation
B. Shelton¹, B. Orandi¹, K. Olthoff², E. Pomfret³, K. Forde², D. Sawinski², M. Gray¹, N. Ascher⁴, J. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Pennsylvania, Philadelphia, PA, ³University of Colorado School of Medicine, Aurora, CO, ⁴University of California San Francisco, San Francisco, CA
*Purpose: Non-alcoholic steatohepatitis (NASH) has emerged as a leading cause of cirrhosis, and obesity-associated comorbid conditions, including renal disease have become more prevalent. Obesity predisposes…
2021 American Transplant Congress
Liver Transplantation in Septuagenarians
L. Egbert¹, D. Das¹, S. Ohara², J. Wagler³, G. Mahdi⁴, B. Aqel⁵, A. Moss⁵, K. S. Reddy⁵, C. Jadlowiec⁵
¹Mayo Clinic Alix School of Medicine, Scottsdale, AZ, ²Valleywise Health General Surgery Residency Program, Phoenix, AZ, ³HonorHealth John C. Lincoln, Phoenix, AZ, ⁴Mayo Clinic Alix School of Medicine, Phoenix, AZ, ⁵Mayo Clinic, Phoenix, AZ
*Purpose: The average age of liver transplant (LT) recipients has continued to increase. In spite of this, with the ongoing organ shortage, liver transplantation in…
2021 American Transplant Congress
Intrahepatic Spatial Location of HCC Recurrence Following Loco-regional Therapy for Solitary Tumors Predicts a Higher Oncologic Risk & Increased Recurrence Post-transplant
A. Mathur, E. Baughan, S. Haider, A. Griesemer, T. Kato, J. Emond
Columbia University, New York, NY
*Purpose: Loco-Regional therapy (LRT) for hepatocellular carcinoma (HCC) patients is an established bridge to Orthotopic Liver Transplantation (OLT). However, no large cohort data exist correlating…